Anyone familiar with the controversy over transgender medicine knows what is going on. Activists put pressure on Springer to retract an article with conclusions they didn’t like, and Springer caved in. We’ve become accustomed to seeing these capitulations in academia, media and the corporate world, but it is especially disturbing to see in a respected medical journal.
Rather than appreciate the long-term risk to itself and the scientific community from doing the bidding of activists, Springer has instead agreed to evaluate and retract all survey papers that lack the newly required consent. If Springer follows through on its promise, hundreds of authors who chose to publish in Springer’s journals may have their research retracted.